Substance use disorders are complicated and recovery is a long road for most people. Even with mental support from doctors and loved ones, it isn't always enough. The physical effects of withdrawal can be so dramatic that medication to subdue the symptoms of withdrawal are the best options for many people. Medication Assisted Recovery (also known as Medication Assisted Treatment) is proven to be an effective mode of recovery for people with substance use disorders.
How The Medications Work
Office-based opioid agonist/ antagonist that blocks other narcotics while reducing withdrawal risk; daily dissolving tablet, cheek film, or 6-month implant under the skin.
"Unlike methadone treatment, which must be performed in a highly structured clinic, buprenorphine is the first medication to treat opioid dependency that is permitted to be prescribed or dispensed in physician offices, significantly increasing treatment access.
Buprenorphine offers several benefits to those with opioid dependency and to others for whom treatment in a methadone clinic is not preferred or is less convenient. The FDA has approved the following buprenorphine products:
- Bunavail (buprenorphine and naloxone) buccal film
- Suboxone (buprenorphine and naloxone) film
- Zubsolv (buprenorphine and naloxone) sublingual tablets
- Buprenorphine-containing transmucosal products for opioid dependency
Buprenorphine has unique pharmacological properties that help:
- Lower the potential for misuse
- Diminish the effects of physical dependency to opioids, such as withdrawal symptoms and cravings
- Increase safety in cases of overdose"
Clinic-based opioid agonist that does not block other narcotics while preventing withdrawal while taking it; daily liquid dispensed only in specialty regulated clinics.
"Methadone works by changing how the brain and nervous system respond to pain. It lessens the painful symptoms of opiate withdrawal and blocks the euphoric effects of opiate drugs such as heroin, morphine, and codeine, as well as semi-synthetic opioids like oxycodone and hydrocodone.
Patients taking methadone to treat opioid addiction must receive the medication under the supervision of a physician. After a period of stability (based on progress and proven, consistent compliance with the medication dosage), patients may be allowed to take methadone at home between program visits. By law, methadone can only be dispensed through an opioid treatment program (OTP) certified by SAMHSA."
*All information provided by the Substance Abuse and Mental Health Services Administration
Office-based non-addictive opioid antagonist that blocks the effects of other narcotics; daily pill or monthly injection.
"Naltrexone blocks the euphoric and sedative effects of drugs such as heroin, morphine, and codeine. It works differently in the body than buprenorphine and methadone, which activate opioid receptors in the body that suppress cravings. Naltrexone binds and blocks opioid receptors, and is reported to reduce opioid cravings. There is no abuse and diversion potential with naltrexone.
If a person relapses and uses the problem drug, naltrexone prevents the feeling of getting high. People using naltrexone should not use any other opioids or illicit drugs; drink alcohol; or take sedatives, tranquilizers, or other drugs."
445 S Sheridan RD
Tulsa, OK 74145
Rightway Medical has offices in Bartlesville, McAlester, Oklahoma City, Ponca City, Roland, and Tulsa. Please visit their website for more information on each location.
Oklahoma Treatment Services exists to provide treatment options for those struggling with opioid addiction. We provide both methadone and suboxone treatment in each of our facilities. Along with treatment, we also provide individual counseling to our patients that will help our patients progress and succeed in our treatment program.
- Walsh, Lynn. “Buprenorphine.” SAMHSA, US Department of Health and Human Services, 7 May 2019, www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine.
- Walsh, Lynn. “Methadone.” SAMHSA, US Department of Health and Human Services, 1 Aug. 2019, www.samhsa.gov/medication-assisted-treatment/treatment/methadone.
- Walsh, Lynn. “Naltrexone.” SAMHSA, US Department of Health and Human Services, 7 May 2019, www.samhsa.gov/medication-assisted-treatment/treatment/naltrexone.